Abstract
Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with capabilities of self-renewal, differentiation, and tumorigenicity. Successful cancer treatment would need to eliminate CSCs. The CSCs can be identified and isolated by both CSC-specific cell surface marker expression and functional assay, such as floating spheres, and aldehyde dehydrogenase (ALDH) activity assay. However, lack of universal expression of surface markers limits their usage to identify CSCs. Here, we give a brief overview of the current known surface markers of CSCs and associated tumor types. Finally, the possible reasons for contradiction are discussed in these surface markers. In this review, I not only provide an overview of the current known surface markers but also highlight the importance of achieving maximal accuracy of a new marker.
Keywords: Aldehyde dehydrogenase, cancer stem cells, differentiation, surface marker, self-renew.
Current Stem Cell Research & Therapy
Title:Surface Markers of Cancer Stem Cells in Solid Tumors
Volume: 9 Issue: 2
Author(s): Pu Xia
Affiliation:
Keywords: Aldehyde dehydrogenase, cancer stem cells, differentiation, surface marker, self-renew.
Abstract: Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with capabilities of self-renewal, differentiation, and tumorigenicity. Successful cancer treatment would need to eliminate CSCs. The CSCs can be identified and isolated by both CSC-specific cell surface marker expression and functional assay, such as floating spheres, and aldehyde dehydrogenase (ALDH) activity assay. However, lack of universal expression of surface markers limits their usage to identify CSCs. Here, we give a brief overview of the current known surface markers of CSCs and associated tumor types. Finally, the possible reasons for contradiction are discussed in these surface markers. In this review, I not only provide an overview of the current known surface markers but also highlight the importance of achieving maximal accuracy of a new marker.
Export Options
About this article
Cite this article as:
Xia Pu, Surface Markers of Cancer Stem Cells in Solid Tumors, Current Stem Cell Research & Therapy 2014; 9 (2) . https://dx.doi.org/10.2174/1574888X09666131217003709
DOI https://dx.doi.org/10.2174/1574888X09666131217003709 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
99mTc-labeling of Peptidomimetic Antagonist to Selectively Target αvβ3 Receptor-Positive Tumor: Comparison of PDA and EDDA as Co-Ligands
Current Radiopharmaceuticals Analgesic Effects and Assays of Controlled-Release Tramadol and O-Desmethyltramadol in Cancer Patients with Pain
Current Pharmaceutical Biotechnology Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Acute Hypersensitivity Reactions to Chemotherapy Agents: An Overview
Inflammation & Allergy - Drug Targets (Discontinued) Expression and Characterisation of Recombinant Molecules in Transgenic Soybean
Current Pharmaceutical Design Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
Current Cancer Drug Targets Fucose Specific Lectins in Cancer Research and Diagnosis
Drug Design Reviews - Online (Discontinued) New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors
Current Cancer Drug Targets Non-Invasive Approaches to Visualize the Endothelin Axis In Vivo Using State-of-the-Art Molecular Imaging Modalities
Mini-Reviews in Medicinal Chemistry Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers
Recent Patents on Anti-Cancer Drug Discovery Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy
Current Topics in Medicinal Chemistry Bioprospecting for Functionally-Proficient Potential Probiotics
Current Nutrition & Food Science E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
Current Diabetes Reviews Chemokines as Pharmacological Targets
Mini-Reviews in Medicinal Chemistry Strategies for In Vivo siRNA Delivery in Cancer
Mini-Reviews in Medicinal Chemistry Majra Honey Abrogated the Normal and Cancer Cells Proliferation Inhibition by Juniperus procera Extract and Extract/Honey Generated AgNPs
Anti-Cancer Agents in Medicinal Chemistry Recurrence in Bladder Cancer: A Molecular Dead End?
Current Genomics